266 related articles for article (PubMed ID: 8625070)
41. Hilar bile duct cancer associated with preoperatively undetectable von Meyenburg complex--report of a case.
Eguchi S; Tajima Y; Yanaga K; Okudaira S; Furui J; Hayashi T; Kanematsu T
Hepatogastroenterology; 2004; 51(59):1301-3. PubMed ID: 15362738
[TBL] [Abstract][Full Text] [Related]
42. Hilar cholangiocarcinoma with intratumoral calcification: A case report.
Inoko K; Tsuchikawa T; Noji T; Kurashima Y; Ebihara Y; Tamoto E; Nakamura T; Murakami S; Okamura K; Shichinohe T; Hirano S
World J Gastroenterol; 2015 Oct; 21(38):10926-30. PubMed ID: 26478684
[TBL] [Abstract][Full Text] [Related]
43. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
Tischoff I; Tannapfel A
Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
[TBL] [Abstract][Full Text] [Related]
44. CT Differentiation of cholangiocarcinoma from periductal fibrosis in patients with hepatolithiasis.
Park HS; Lee JM; Kim SH; Jeong JY; Kim YJ; Lee KH; Choi SH; Han JK; Choi BI
AJR Am J Roentgenol; 2006 Aug; 187(2):445-53. PubMed ID: 16861550
[TBL] [Abstract][Full Text] [Related]
45. Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.
Huang XW; Huang Y; Chen LD; Wang Z; Yang Z; Liu JY; Xie XY; Lu MD; Shen SL; Wang W
J Med Ultrason (2001); 2018 Apr; 45(2):231-241. PubMed ID: 29052791
[TBL] [Abstract][Full Text] [Related]
46. Transpapillary biliary biopsy for malignant biliary strictures: comparison between cholangiocarcinoma and pancreatic cancer.
Chen WM; Wei KL; Chen YS; Chang PJ; Tung SY; Chang TS; Huang HC; Shen CH; Hsieh YY; Wu CS
World J Surg Oncol; 2016 May; 14():140. PubMed ID: 27142076
[TBL] [Abstract][Full Text] [Related]
47. Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases.
Yano Y; Yamamoto J; Kosuge T; Sakamoto Y; Yamasaki S; Shimada K; Ojima H; Sakamoto M; Takayama T; Makuuchi M
Jpn J Clin Oncol; 2003 Jun; 33(6):283-7. PubMed ID: 12913082
[TBL] [Abstract][Full Text] [Related]
48. Clinicopathologic features in patients with long-term survival following resection for intrahepatic cholangiocarcinoma.
Uenishi T; Hirohashi K; Kubo S; Yamamoto T; Yamazaki O; Shuto T; Tanaka H; Kinoshita H
Hepatogastroenterology; 2003; 50(52):1069-72. PubMed ID: 12845984
[TBL] [Abstract][Full Text] [Related]
49. Impact of Tumor Subclassifications for Identifying an Appropriate Surgical Strategy in Patients with Intrahepatic Cholangiocarcinoma.
Kinoshita M; Sato Y; Shinkawa H; Kimura K; Ohira G; Nishio K; Tanaka R; Kurihara S; Kushiyama S; Tani N; Kawaguchi T; Yamamoto A; Ishizawa T; Kubo S
Ann Surg Oncol; 2024 Apr; 31(4):2579-2590. PubMed ID: 38180706
[TBL] [Abstract][Full Text] [Related]
50. What is the impact of coexistence of hepatolithiasis on cholangiocarcinoma?
Lee CC; Wu CY; Chen GH
J Gastroenterol Hepatol; 2002 Sep; 17(9):1015-20. PubMed ID: 12167124
[TBL] [Abstract][Full Text] [Related]
51. Investigation of Factors Affecting the Sensitivity of Bile Duct Brush Cytology.
Kobayashi M; Ryozawa S; Araki R; Nagata K; Tanisaka Y; Fujita A; Kobatake T
Intern Med; 2019 Feb; 58(3):329-335. PubMed ID: 30146607
[TBL] [Abstract][Full Text] [Related]
52. A resected case of a small hepatocellular carcinoma developing within the bile duct.
Yasui O; Sato T; Andoh H; Kurokawa T; Watanabe D; Sageshima M; Nanjo H
J Hepatobiliary Pancreat Surg; 2004; 11(3):193-6. PubMed ID: 15235893
[TBL] [Abstract][Full Text] [Related]
53. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases.
Ebata T; Nagino M; Kamiya J; Uesaka K; Nagasaka T; Nimura Y
Ann Surg; 2003 Nov; 238(5):720-7. PubMed ID: 14578735
[TBL] [Abstract][Full Text] [Related]
54. Mass-forming intrahepatic cholangiocarcinoma presenting with painful obstructive hemobilia.
Coulier B; Maldague P; Ramboux A; Gielen I
JBR-BTR; 2014; 97(6):366-9. PubMed ID: 25786297
[TBL] [Abstract][Full Text] [Related]
55. Preoperative serum CA19-9 levels is an independent prognostic factor in patients with resected hilar cholangiocarcinoma.
Cai WK; Lin JJ; He GH; Wang H; Lu JH; Yang GS
Int J Clin Exp Pathol; 2014; 7(11):7890-8. PubMed ID: 25550829
[TBL] [Abstract][Full Text] [Related]
56. Wisteria floribunda agglutinin-sialylated mucin core polypeptide 1 is a sensitive biomarker for biliary tract carcinoma and intrahepatic cholangiocarcinoma: a multicenter study.
Shoda J; Matsuda A; Shida T; Yamamoto M; Nagino M; Tsuyuguchi T; Yasaka T; Tazuma S; Uchiyama K; Unno M; Ohkohchi N; Nakanuma Y; Kuno A; Narimatsu H
J Gastroenterol; 2017 Feb; 52(2):218-228. PubMed ID: 27358229
[TBL] [Abstract][Full Text] [Related]
57. An Unusual Presentation of Advanced Intrahepatic Cholangiocarcinoma: When Biopsy Results Fail.
Tasch JJ; Dube N
Am J Case Rep; 2018 Jan; 19():35-40. PubMed ID: 29317591
[TBL] [Abstract][Full Text] [Related]
58. High serum CA19-9 levels are associated with an increased risk of cholangiocarcinoma in patients with intrahepatic duct stones: a case-control study.
Jo JH; Chung MJ; Park JY; Bang S; Park SW; Kim KS; Lee WJ; Song SY; Chung JB
Surg Endosc; 2013 Nov; 27(11):4210-6. PubMed ID: 23760942
[TBL] [Abstract][Full Text] [Related]
59. Left hemihepatectomy and caudate lobectomy and complete extrahepatic bile duct resection using transduodenal approach for hilar cholangiocarcinoma arsing from biliary papillomatosis.
Kim JK; Hwang HK; Park JS; Cho SI; Yoon DS; Chi HS
J Surg Oncol; 2008 Aug; 98(2):139-42. PubMed ID: 18521837
[TBL] [Abstract][Full Text] [Related]
60. Surgical management of cholangiocarcinoma.
Jarnagin WR; Shoup M
Semin Liver Dis; 2004 May; 24(2):189-99. PubMed ID: 15192791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
